PT-141 serves as a cutting-edge cyclic melanocortin agonist that demonstrates potential in the treatment of sexual dysfunction. This novel compound functions by activating specific receptors within the body, causing to improved sexual response. Clinical studies have revealed that PT-141 has the potential to significantly treat a spectrum of sexual